medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2023, Number 4

<< Back Next >>

Acta Med 2023; 21 (4)

Clostridioides difficile

Díaz GEJ, Corona DA, Katsuda MYA, Reyes MCL

Language: Spanish
References: 18
Page: 368-371
PDF size: 169.50 Kb.


ABSTRACT

Clostridioides difficile is recognized as the most common cause of nosocomial diarrhea and represents a challenge in public health. 50 to 75% of Clostridioides difficile colitis is related to the use of antibiotics. Fidaxomicin, metronidazole, or vancomycin can be used as antibiotic treatment.


REFERENCES

  1. Goycochea-Valdivia WA, Capilla Miranda A, García Malagón C. Tratamiento antibiótico de la infección por Clostridioides difficile en niños: nuevas evidencias y perspectivas futuras. Rev Latin Infect Pediatr. 2022; 35 (2): 60-63.

  2. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66 (7): e1-e48. doi: 10.1093/cid/cix1085.

  3. Abreu y Abreu A, Velarde-Ruiz J, Zavala-Solares M, Remes-Troche J, Carmona-Sánchez R, Aldana-Ledesma J et al. Consenso sobre prevención, diagnóstico y tratamiento de la infección por Clostridium difficile. Rev Gastroenterol Mex. 2019; 84 (2): 204-219. doi: 10.1016/j.rgmx.2018.12.001.

  4. Finn E, Andersson F, Madin-Warburton M. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis. 2021; 21 (1): 456. doi: 10.1186/s12879-021-06147-y.

  5. Morfin-Otero R, Garza-Gonzalez E, Aguirre-Diaz S, Escobedo-Sanchez R, Esparza-Ahumada S, Perez-Gomez H et al. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital. Braz J Infect Dis. 2016; 20 (1): 8-13. doi: 10.1016/j.bjid.2015.09.008.

  6. Ochoa-Hein E, Sifuentes-Osornio J, Ponce de León A, Torres-González P, Granados-García V, Galindo-Fraga A. Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study. PLoS One. 2018; 13 (5): e0198212. doi: 10.1371/journal.pone.0198212.

  7. Sandhu B, McBride S. Clostridioides difficile. Trends Microbiol. 2018; 26 (12): 1049-1050. doi: 10.1016/j.tim.2018.09.004.

  8. Czepiel J, Drozdz M, Pituch H, Kuijper E, Perucki W, Mielimonka A et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019; 38 (7): 1211-1221. doi: 10.1007/s10096-019-03539-6.

  9. Somily A, Aatif M, Morshed M. The laboratory diagnosis of Clostridioides difficile infection: an update of current laboratory practice. J Infect Dev Ctries. 2021; 15 (10): 1364-1375. doi: 10.3855/jidc.13217.

  10. Guh A, Kutty P. Clostridioides difficile infection. Ann Intern Med. 2018; 169 (7): ITC49-ITC64. doi: 10.7326/AITC201810020.

  11. van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021; 27 Suppl 2: S1-S21. doi: 10.1016/j.cmi.2021.09.038.

  12. Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis. 2012; 55 Suppl 2 (Suppl 2): S154-S161. doi: 10.1093/cid/cis462.

  13. Bhangu A, Nepogodiev D, Gupta A, Torrance A, Singh P; West Midlands Research Collaborative. Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis. Br J Surg. 2012; 99 (11): 1501-1513. doi: 10.1002/bjs.8868.

  14. Ferrada P, Callcut R, Zielinski MD, Bruns B, Yeh DD, Zakrison TL et al. Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile-associated disease: An Eastern Association for the Surgery of Trauma multicenter trial. J Trauma Acute Care Surg. 2017; 83 (1): 36-40.

  15. Martín-de-Carpi J. Infección por Clostridium difficile en la enfermedad inflamatoria intestinal. Rev Esp Enferm Dig. 2015; 107 (1): 1-3. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082015000100001&lng=es

  16. Ruiter-Ligeti J, Vincent S, Czuzoj-Shulman N, Abenhaim HA. Risk factors, incidence, and morbidity associated with obstetric Clostridium difficile infection. Obstet Gynecol. 2018; 131 (2): 387-391. doi: 10.1097/AOG.0000000000002422.

  17. Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN et al. ACG Clinical Guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021; 116 (6): 1124-1147. [Erratum in: Am J Gastroenterol. 2022; 117 (2): 358].

  18. Quraishi MN, Widlak M, Bhala N, Moore D, Price M, Sharma N et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017; 46 (5): 479-493. doi: 10.1111/apt.14201.




2020     |     www.medigraphic.com